BioScrip (BIOS) Names Smith as President, COO
More News related to BIOS
- BioScrip, Inc. to Present at Credit Suisse 18th Annual Healthcare Conference
- BioScrip (BIOS) Posts Q3 EPS of $0.14, Tops by 4c
- Trading Radar for 10/30: Sony (SNE), Penske (PAG), Alcatel-Lucent (ALU) Report
- Trading Review for Allion Healthcare Inc. Issued by Beacon Equity
- BioScrip to Host Third Quarter 2009 Earnings Call
More News related to Management Changes
- AIG's Vice Chairman, Jacob Frenkel, to Retire
- AIG CEO Benmosche Threatens to Leave
- Ultralife (ULBI) CFO Casper Resigns; Fain to Act as CFO on Interim
- AIG (AIG) CEO Considers Leaving
- Burger King (BKC) Announces Resignation of the Company's President, Gglobal Marketing Strategy & Innovation
BioScrip, Inc. (Nasdaq: BIOS) today announced that Richard Smith has been appointed as its President and COO.
BioScrip, Inc., a specialty pharmaceutical healthcare organization, provides medications and management solutions for chronic and other healthcare conditions in the United States.
Related Categories
Management ChangesStocks Mentioned
+0.38Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
